CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 67 filers reported holding CHEMOCENTRYX INC in Q3 2015. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $35,343,000 | +57.2% | 684,161 | -24.6% | 0.01% | +66.7% |
| Q2 2022 | $22,485,000 | +112.3% | 907,386 | +114.8% | 0.00% | +200.0% |
| Q1 2022 | $10,592,000 | -25.1% | 422,509 | +8.7% | 0.00% | -50.0% |
| Q4 2021 | $14,148,000 | +398.2% | 388,604 | +133.9% | 0.00% | – |
| Q3 2021 | $2,840,000 | -45.4% | 166,139 | -57.2% | 0.00% | -100.0% |
| Q2 2021 | $5,197,000 | -71.2% | 388,061 | +10.1% | 0.00% | -66.7% |
| Q1 2021 | $18,059,000 | +402.3% | 352,454 | +507.1% | 0.00% | +200.0% |
| Q4 2020 | $3,595,000 | +108.9% | 58,058 | +84.9% | 0.00% | – |
| Q3 2020 | $1,721,000 | -70.0% | 31,403 | -68.5% | 0.00% | -100.0% |
| Q2 2020 | $5,736,000 | +331.9% | 99,688 | +201.4% | 0.00% | – |
| Q1 2020 | $1,328,000 | -63.4% | 33,073 | -64.0% | 0.00% | -100.0% |
| Q4 2019 | $3,629,000 | +257.2% | 91,758 | -38.8% | 0.00% | – |
| Q3 2019 | $1,016,000 | +1853.8% | 149,900 | +2581.1% | 0.00% | – |
| Q2 2019 | $52,000 | -79.5% | 5,591 | -69.5% | 0.00% | – |
| Q1 2019 | $254,000 | -41.2% | 18,304 | -53.7% | 0.00% | – |
| Q4 2018 | $432,000 | -29.8% | 39,571 | -18.8% | 0.00% | – |
| Q3 2018 | $615,000 | -14.9% | 48,745 | -11.3% | 0.00% | – |
| Q2 2018 | $723,000 | -42.9% | 54,946 | -41.0% | 0.00% | – |
| Q1 2018 | $1,267,000 | +41.7% | 93,203 | -37.9% | 0.00% | – |
| Q4 2017 | $894,000 | +31.3% | 150,072 | +63.6% | 0.00% | – |
| Q3 2017 | $681,000 | -37.3% | 91,749 | -20.8% | 0.00% | – |
| Q2 2017 | $1,086,000 | -39.4% | 115,865 | -53.0% | 0.00% | – |
| Q1 2017 | $1,792,000 | +9.3% | 246,342 | +11.1% | 0.00% | – |
| Q4 2016 | $1,640,000 | +1626.3% | 221,722 | +1304.5% | 0.00% | – |
| Q3 2016 | $95,000 | -61.7% | 15,787 | -71.4% | 0.00% | – |
| Q2 2016 | $248,000 | +1027.3% | 55,184 | +528.7% | 0.00% | – |
| Q1 2016 | $22,000 | -81.4% | 8,777 | -39.7% | 0.00% | – |
| Q4 2015 | $118,000 | +51.3% | 14,548 | +11.7% | 0.00% | – |
| Q3 2015 | $78,000 | -77.3% | 13,021 | -68.9% | 0.00% | – |
| Q2 2015 | $344,000 | +75.5% | 41,806 | +61.5% | 0.00% | – |
| Q1 2015 | $196,000 | +345.5% | 25,892 | +302.4% | 0.00% | – |
| Q4 2014 | $44,000 | +51.7% | 6,434 | 0.0% | 0.00% | – |
| Q3 2014 | $29,000 | -75.8% | 6,434 | -68.5% | 0.00% | – |
| Q2 2014 | $120,000 | -6.2% | 20,452 | +5.6% | 0.00% | – |
| Q1 2014 | $128,000 | -66.3% | 19,371 | -70.4% | 0.00% | – |
| Q4 2013 | $380,000 | -53.4% | 65,528 | -55.3% | 0.00% | – |
| Q3 2013 | $816,000 | +166.7% | 146,643 | +575.5% | 0.00% | – |
| Q2 2013 | $306,000 | – | 21,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |